Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sven Devos

Ki67 and PIM1 Expression Predict Outcome in Mantle Cell Lymphoma Treated With High Dose Therapy, Stem Cell Transplantation and Rituximab: A Cancer and Leukemia Group B 59909 Correlative Science Study

Leukemia and Lymphoma

English

Related publications

Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply

The Lancet Oncology

Oncology

2017

English

Durable Remission of Mantle Cell Lymphoma Relapsing a Third Time After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Rituximab, Bortezomib, Donor Lymphocytes, and Pegylated Interferon

Clinical Lymphoma, Myeloma and Leukemia

English

High-Dose Chemotherapy and Haematopoietic Stem Cell Transplantation for Inflammatory Breast Cancer: Pathologic Response and Outcome

Bone Marrow Transplantation

Transplantation

Hematology

1998

English

Prospective Clinical Study of R-CMD Therapy for Indolent B Cell Lymphoma and Mantle Cell Lymphoma From the Hokuriku Hematology Oncology Study Group

English

High-Dose Therapy With Autologous Stem Cell Transplantation in Patients With Peripheral T Cell Lymphomas

Bone Marrow Transplantation

Transplantation

Hematology

2001

English

Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Adults With Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Retrospective Analysis in the Rituximab Era

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2014

English

Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2014

English

Efficacy of Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: A 3-Year Follow-Up Study

Bone Marrow Transplantation

Transplantation

Hematology

2000

English

Intensive Induction Chemotherapy Followed by Early High-Dose Therapy and Hematopoietic Stem Cell Transplantation Results in Improved Outcome for Patients With Hepatosplenic T-Cell Lymphoma: A Single Institution Experience.

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sven Devos

Ki67 and PIM1 Expression Predict Outcome in Mantle Cell Lymphoma Treated With High Dose Therapy, Stem Cell Transplantation and Rituximab: A Cancer and Leukemia Group B 59909 Correlative Science Study

Related publications

Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply

Durable Remission of Mantle Cell Lymphoma Relapsing a Third Time After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Rituximab, Bortezomib, Donor Lymphocytes, and Pegylated Interferon

High-Dose Chemotherapy and Haematopoietic Stem Cell Transplantation for Inflammatory Breast Cancer: Pathologic Response and Outcome

Prospective Clinical Study of R-CMD Therapy for Indolent B Cell Lymphoma and Mantle Cell Lymphoma From the Hokuriku Hematology Oncology Study Group

High-Dose Therapy With Autologous Stem Cell Transplantation in Patients With Peripheral T Cell Lymphomas

Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Adults With Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Retrospective Analysis in the Rituximab Era

Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

Efficacy of Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: A 3-Year Follow-Up Study

Intensive Induction Chemotherapy Followed by Early High-Dose Therapy and Hematopoietic Stem Cell Transplantation Results in Improved Outcome for Patients With Hepatosplenic T-Cell Lymphoma: A Single Institution Experience.